Misinterpretation at CT colonography (CTC) can result in either a colorectal lesion being missed (false-negative) or a false-positive diagnosis. This review will largely focus on potential missed lesions-and ways to avoid such misses. The general causes of false-negative interpretation at CTC can be broadly characterized and grouped into discrete categories related to suboptimal study technique, specific lesion characteristics, anatomic location, and imaging artifacts. Overlapping causes further increase the likelihood of missing a clinically relevant lesion. In the end, if the technical factors of bowel preparation, colonic distention, and robust CTC software are adequately addressed on a consistent basis, and the reader is aware of all the potential pitfalls at CTC, important lesions will seldom be missed.
No medical test is infallible, and the unavoidable certainty of both false-negative and false-positive results must be considered in clinical practice. Test sensitivity is typically the single most valued trait, since a false-negative miss of an important disease process (such as colorectal cancer) can have devastating consequences. For CT colonography (CTC), a number of published studies have demonstrated sensitivity values for advanced adenomas and cancers that approaches, equals, or exceeds that of the optical colonoscopy (OC) reference standard [1] [2] [3] [4] [5] . CTC and OC, however, should be considered complementary tests in that the causes for missed lesions are distinct, and important lesions missed by one test are often detected by the other.
Recognized causes of false-negative interpretation at CTC will be systematically reviewed, including discussion on how to minimize missing important lesions. Because ''misses'' in the broad sense should also include false-positive interpretations (which determines test specificity), this topic will be briefly discussed at the end. In the end, it is critical to understand the importance of striking an appropriate balance between sensitivity and specificity, especially for a screening test. Striving for an unrealistically high sensitivity will generally lead to low specificity with an unacceptable false-positive rate. In terms of CTC, this low specificity (manifesting in routine practice as low PPV) will result in too many unnecessary invasive colonoscopy studies. If, however, one strives for an unrealistically high specificity, the likelihood of missing important lesions is increased.
Clinical trial vs. clinical practice setting
It is important to understand the influence that a clinical trial setting can have on test performance, because many trials create an artificial environment that does not actually mirror routine clinical practice. In the case of a typical prospective CTC screening trial, the interpreting radiologist is aware that the subject will go on to OC regardless of whether or not the CTC is positive. This artificial situation could encourage the reader to ''overcall'' potential polyps in order to maintain high test sensitivity, since there is no real penalty (beyond reduced specificity), whereas in routine clinical practice such an overcall would result in unnecessary endoscopy. This may explain the relatively low specificity and PPV seen in some prospective trials [2] . For validation of CTC, however, the situation is made even more complex by the fact that the unavoidable reference standard (OC) is fraught with imperfection [6] .
In routine clinical practice with CTC, neither sensitivity nor specificity can be measured, since only test-positive CTC cases are referred to OC and both false-negative and true-negative interpretations can therefore not be divined. What can be assessed are the true-positive versus false-positive studies, allowing for determination of positive predictive value (PPV), which serves as an important quality measure in clinical practice [7, 8] . In our experience, the PPV for lesions ‡6 mm Fig. 1 . Flat and sessile cecal polyps (tubulovillous adenomas) at CTC. Supine 3D endoluminal (A), 2D polyp window (B), and 2D soft tissue (C) views from CTC show a 2-cm flat lesion (arrows) within the cecum. Not the thin coating of contrast clinging to the flat lesion, but not the surrounding normal mucosa. Prone 2D image with polyp window (D) shows the flat lesion (arrow) submerged under the opacified fluid. Although the iodine tagging allows for detection of submerged polyps, a broad window must be used, as the lesion may be obscured on a soft tissue window (E). Image from OC (F) confirms the flat lesion (arrow). Additional 3D endoluminal CTC image (G) shows a conspicuous 1.3-cm sessile polyp (arrow) adjacent to the flat lesion (arrowhead). The ileocecal valve is seen across from the polyps. Supine 2D images (H and I) confirm the soft tissue nature sessile polyp (arrow), and also show contrast coating. The ileocecal valve is also well seen at this level.
should be generally be above 90% at CTC in routine clinical practice [7] . The true-positive results from CTC can also be used to compare against the expected prevalence of disease (e.g., for advanced neoplasia) [3] . Tracking the number and kind of additional lesions found at OC in CTC positive cases represents a more indirect surrogate measure [9] . Finally, long-term patient outcome studies are important to indirectly assess for important missed lesions [10] . In the end, the high diagnostic accuracy of CTC is largely due to the redundancy in interpretation, as relevant lesions may be seen on 3D and/or 2D evaluation, supine and/or prone, etc. , which proved to be a true polyp, is seen adjacent to polypoid tagged stool. 3D endoluminal images without (B) and with (C) translucency rendering show multiple polyp candidates, but only one true soft tissue lesion (arrows). This degree of residual solid stool makes polyp detection very difficult, even when tagged. In addition, we recommend the use of 2% barium over 40%, which is too dense. 
Missed lesions at CTC (false-negative interpretation)
Causes of false-negative interpretation at CTC can be characterized and grouped into a discrete set of categories (Table 1) . In broad terms, important lesions may be missed because of study technique, specific lesion characteristics, anatomic location, or the presence of imaging artifacts. In many cases, overlapping causes compound the detection difficulty. These categories are discussed below, including ways to minimize truly important pathology.
Misses related to inadequate technique
Inadequate bowel preparation, colonic distention, CT scanning, or interpretation strategies can all result in false-negative interpretation. To minimize errors related to the bowel preparation, we strongly advocate the use of a cathartic preparation (e.g., magnesium citrate) with oral contrast tagging [11] [12] [13] [14] [15] . The importance of removing bulk stool and tagging any residual material for lesion detection is obvious to anyone who has interpreted CTC (Fig. 1 ). For any solid or semi-solid fecal material that remains after catharsis, effective tagging with oral contrast (preferably 2% barium) can reduce both false-positive (discussed below) and false-negative interpretation. A thin coating of oral contrast along the surface of true polyps, with sparing of the surrounding normal mucosa, is an extremely useful finding that effectively serves as a beacon for detection at CTC ( Fig. 1) [13, 16] . Even more important than barium tagging is the use of diatrizoate (Gastrografin) to wash off adherent debris and to uniformly opacify the residual colonic fluid, which allows for detection of submerged lesions ( Fig. 1) . Although the regions of the colon under fluid on supine are almost always free of fluid on the prone view, the ability to confirm a suspected lesion on the second view vastly increases diagnostic confidence. For same-day CTC following incomplete OC, administering a small oral dose (20-30 mL) of Gastrografin often results in excess luminal fluid but opacification is still preferable to the alternative of not tagging [17] . The issue of residual solid stool related to ''minimal prep'' or noncathartic approaches is important, as it may limit interpretation to a primary 2D approach, which results in suboptimal detection relative to a combined 3D/2D detection strategy (Fig. 2) [12, 18] .
Inadequate colonic distention of the left colon is the major cause of a technically inadequate CTC [13] . There is no doubt that the use of automated low-pressure CO 2 delivery improves the quality of distention and reduces post-procedural discomfort relative to room air [19, 20] . A dedicated CO 2 delivery device (PROTOCO 2 L, Bracco) should be considered the standard of care for routine CTC. With regard to spasmolytic use in the U.S., glucagon does not provide significant benefit at CTC and should generally be avoided [21] . Some investigators have shown improved distention with Buscopan (hyoscine butylbromide) [22] , but this agent is not available for use in the U.S. Suboptimal distention of a colonic segment should be distinguished from inadequate distention, as the former state is often diagnostic but the latter generally is not. To truly assess adequacy of distention, one must compare the supine and prone images. When there is complete or near-complete collapse of a given segment on both views, such that relevant lesions cannot be excluded, then the study is considered nondiagnostic-at least for that particular segment (Fig. 3) . In such cases, obtaining an additional series with lateral decubitus positioning is the best way to salvage the examination (Fig. 4) [23] . Not infrequently, however, ''non-diagnostic'' segments are actually caused by real pathology-typically a sigmoid diverticular stricture.
CTC is recognized as a low-dose CT evaluation. The conspicuity of soft tissue polyps against the gas-filled lumen allows for significant dose reduction compared with most diagnostic abdominal CT exams. However, when dose reduction is too aggressive, diagnostic quality for lesion detection can be severely compromised, especially on the 3D endoluminal view (Fig. 5) . Low-dose artifact is particularly troublesome in morbidly obese patients (Fig. 5) . Newer iterative CT reconstruction algorithms can help to reduce or eliminate noise related to the traditional filtered back-projection (FBP) technique (Fig. 6) [24, 25] .
It has been recognized dating back to the earliest CTC trials that the specific interpretation strategy employed for polyp detection at CTC can lead to missed lesions. In particular, reliance on a primary 2D search pattern, with 3D views reserved for ''problem solving'' will generally result in reduced performance compared Fig. 7 . Primary 3D versus primary 2D polyp detection at CTC. 3D (A) and 2D (B) images from CTC show a 9-mm polyp (arrow) in the sigmoid colon. The polyp is easy to distinguish from adjacent folds on 3D, but the task is much more difficult on the 2D view alone (without the arrow, at least). The lesion was confirmed at same-day OC (C) and proved to be hyperplastic.
with a combined primary 3D and 2D approach [13, 18, 26, 27] . For anyone with experience interpreting CTC, the fact that polyps can be easily missed on 2D review comes as no surprise, as the distinction between polyps and folds that is so obvious on 3D is quite challenging on 2D (Fig. 7) . Rather, the 2D display should be thought of Fig. 8 . Spatial distortion obscuring a large rectal mass at CTC. 3D virtual dissection with 360°display (plus overlap) (A) shows subtle irregularity where the yellow line intersects. The same area in the rectum is shown on the 120°strip (B), which begins to show a mass lesion. On the standard 3D endoluminal view (C), the lobulated carpet lesion (arrowheads) between rectal folds is more apparent. This proved to be a large villous adenoma with high-grade dysplasia at OC (D).
as more the source images for ultimately confirming all soft tissue polyps. Polyp detection on 2D can serve as an important supplement to 3D, but it is important to initially view the images in a wide ''polyp window'' (W: 2000 HU, L; 0 HU), reserving the soft tissue window for secondary evaluation (Fig. 1) . This issue of primary 2D misses also becomes relevant in terms of non-cathartic approaches to colonic preparation, since primary 3D evaluation is simply not practical in the setting of abundant residual solid stool-whether tagged or not [12] . Another interpretation strategy that can lead to significant misses is primary reliance on a 3D virtual dissection or filet view, which unavoidably distorts the colonic anatomy, obscuring even large polyps and masses (Fig. 8) [28, 29] .
Misses related to intrinsic lesion characteristics
Polyp morphology and size both play an important role in determining lesion conspicuity at CTC. In general, relatively flat or plaque-like lesions are less conspicuous at CTC (or any imaging test) relative to more protruding sessile or pedunculated lesions (Fig. 1) . There has been considerable recent interest and debate surrounding the importance of flat lesions in terms of cancer risk and the precise pathway(s) involved. In our experience, flat lesions are much less common than polypoid lesions, and are much less likely to be neoplastic, histologically advanced, or frankly malignant [30, 31] . It should be noted that virtually all flat colorectal lesions are minimally raised (with or without a central depression) and are not completely flat [32] . As such, these lesions are detectable at CTC, but require excellent technique in terms of preparation, distention, and interpretation. Both 3D and 2D evaluation are necessary to optimize detection of flat lesions. As noted above, a thin coating of oral contrast along the surface of the lesion is quite helpful in diagnosis, especially for flat lesions (Fig. 1) [13, 16] . Carpet lesions, also known as laterally spreading tumors, are greater than 3 cm in size and tend to involve the cecum and rectum. Because these segments are easily distended, these flat masses tend to be well visualized at CTC (Fig. 9) .
Polyp size directly affects lesion conspicuity at CTC-and other colonic imaging tests. CTC is clearly less accurate for diminutive lesions, which measure 5 mm or less in diameter. Although polyp prevalence is inversely related to lesion size, the clinical relevance of polyps increases in direct relation to size [33] . For a number of reasons, we purposefully do not report isolated diminutive lesions at CTC, which therefore represent ''missed lesions'' by design. Most importantly, reporting a potential diminutive polyp could lead to inappropriate colonoscopy, for which the risks of the procedure generally outweigh the potential benefits. An additional consideration is the difficulty and time required to correlate such diminutive findings at OC. Even if a diminutive lesion is found to be a true soft tissue polyp, the likelihood of a histologically advanced lesion is very low [34] [35] [36] . The low rate of significant pathology seen at 5-year CTC follow-up further supports the practice of non-reporting of potential diminutive lesions [10] .
Misses related to anatomic location
Beyond the usual haustrated tubular appearance to most of the large intestine, there are a few specific anatomic areas that warrant special attention, including the low Fig. 11 . Adenoma located on the ileocecal valve (missed at prospective CTC). 3D endoluminal CTC image (A) shows a focal contour abnormality (arrowhead) to the ileocecal valve, which is a relatively common finding. However, on translucency rendering (B), this focal area showed soft tissue signature (red), compared with the fatty valve (green). At OC (C), an adenoma was found on the valve at this location. (from Ref. [37] with permission).
rectum, the ileocecal valve region, and the left colon when advanced diverticular disease is present. The anorectal region is particularly problematic, as a number of pitfalls exist that could lead to both false-negative and false-positive results. The wide array of unique pathology in this area (e.g., hypertrophic anal papillae and internal hemorrhoids), coupled with the presence of the rectal balloon catheter and funneled narrowing toward the anal canal, make for an often challenging evaluation that can obscure significant pathology (Fig. 10) [37, 38] . This is the single most common location of missed cancers at CTC [5] . Steps to minimizing missed lesions in the anorectal region include a general awareness of the various focal lesions, careful 3D fly-through and multiplanar 2D assessment, and deflation of the rectal catheter balloon for the prone series. Because CTC does not provide for adequate evaluation of the anal canal, digital rectal examination should continue to be part of the routine physical.
Lesions on or near the ileocecal valve can be challenging to diagnose at CTC, related in part to the various polypoid appearances of the valve itself (Fig. 11) [39] . As with the low rectal region, familiarity with the normal varied appearances of the ileocecal valve and dedicated 3D/2D evaluation at CTC will prevent important misses. I find the translucency view at 3D CTC to be especially helpful, as focal soft tissue lesions on a fatty valve become quite apparent (Fig. 11) [40] .
Advanced diverticular disease of the sigmoid colon is a common finding in older adults and results in significant challenges at both colonoscopy and CTC interpretation [41] [42] [43] . The wall thickening, luminal narrowing, and resistance to distention related to myochosis are the major causes of difficulty-and not the diverticula themselves. Sigmoid diverticular disease is far and away the leading cause of inadequate colonic distention at CTC. A right lateral decubitus series is frequently needed to achieve adequate evaluation in cases of advanced diverticular disease (Fig. 4) . In our experience, automated CO 2 is much more successful than room air for yielding diagnostic distention. As long as luminal distention allows for 3D endoluminal fly-through, polyp detection is not significantly impacted (Fig. 12) [41] . However, in cases where evaluation is limited to 2D evaluation, relevant lesions can easily be missed.
Misses related to imaging artifacts
There are a number of imaging artifacts seen at CTC that must be recognized, as they may lead to missed lesions. Spatial distortion related to alternative 3D displays such as the dissection or filet view has already been discussed. Artifacts related to ''electronic cleansing'' or digital subtraction of contrast-tagged fluid on the 3D endoluminal view are important to recognize [14] . Because of our negative experience with this in the DoD screening trial, we have never employed electronic cleansing for interpretation of cases at the University of Wisconsin CTC program. Regardless, one should never ''cleanse'' the 2D images, since the cross-sectional nature already allows for distinction between tagged stool and lesions submerged or coated by contrast. The 2D series represent the source images that should remain unadulterated. For the 3D endoluminal view, we rely on shifting of the fluid pool between supine and prone positioning to uncover submerged lesions. The lack of induced artifacts on 3D makes for a much more rapid and reliable assessment.
Beam-hardening artifacts related to metallic hip prostheses or spinal hardware can severely limit colorectal evaluation (Fig. 13) . This is particularly important in the low rectum, where other pitfalls already exist, as described above. Improvements in CT image reconstruction technique beyond the traditional FBP methodology should reduce these artifacts in the near future. Finally, we have noticed a common reconstruction artifact that is somewhat unique to CTC that results from the intra-scan flow of opacified endoluminal fluid (Fig. 14) [44] . The active motion of the tagged fluid creates an artifact that we have termed the ''dense waterfall'' sign, which can largely obscure the underlying colonic anatomy. The underlying cause is easy to recognize, as the flowing fluid has an appearance that is characteristic and distinct from static fluid levels. Fortunately, the involved area is essentially never affected by the artifact on the alternative view (prone or supine).
Overcalling pathology at CTC (false-positive interpretation)
There are many potential pitfalls at CTC that could lead to false-positive result, which are summarized in Table 2 . Detailed discussion of these entities is beyond the scope of this review, but can be found elsewhere [45] . Because not all positive findings carry the same PPV [7] , we have found it useful to prospectively assign a diagnostic confidence score [46] . For high confidence findings (e.g., a large pedunculated polyp), the colonoscopist knows to keep looking if not initially found, whereas for low confidence findings (e.g., a subtle potential flat lesion), a false-positive CTC result may be more acceptable. For all discordant cases where a called lesion at CTC is not found at subsequent OC, we review the case by committee to decide whether a CTC false-positive or OC false-negative result is most likely, which determines future management.
Summary
In conclusion, misinterpretation at CTC can result in either missed lesions or false-positive diagnosis. This review has focused largely on missed lesions-and ways to minimize mistakes. If the technical factors of bowel preparation, colonic distention, and robust CTC software are adequately addressed on a consistent basis, and the reader is aware of all the potential pitfalls at CTC, important lesions will seldom be missed.
